These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10566003)

  • 1. Tresperimus. LF 080299.
    Drugs R D; 1999 Jan; 1(1):110-1. PubMed ID: 10566003
    [No Abstract]   [Full Text] [Related]  

  • 2. Tresperimus (Laboratoires Fournier).
    Elices MJ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):372-4. PubMed ID: 11575707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 5. Inolimomab. Anti-CD25 monoclonal antibody B-B10, anti-interleukin-2 receptor monoclonal antibody B-B10, B-B10, BT 563, Leukotac.
    Drugs R D; 1999 Jan; 1(1):81-4. PubMed ID: 10565995
    [No Abstract]   [Full Text] [Related]  

  • 6. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 7. SR 31747. Peripheral sigma receptor antagonist.
    Drugs R D; 1999 Jan; 1(1):108-9. PubMed ID: 10566002
    [No Abstract]   [Full Text] [Related]  

  • 8. BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a.
    Drugs R D; 1999 Jan; 1(1):68-70. PubMed ID: 10565990
    [No Abstract]   [Full Text] [Related]  

  • 9. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 10. MEDI 500. Anti-TCR-alpha beta monoclonal antibody T10B9, G 022, T-10B9, T10B9, T10B9 monoclonal antibody, T10B9.1A31, T12A10.
    Drugs R D; 1999 Jan; 1(1):92-4. PubMed ID: 10565998
    [No Abstract]   [Full Text] [Related]  

  • 11. Tresperimus: a new agent for transplant tolerance induction.
    Simpson D
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1381-6. PubMed ID: 11772258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Jan; 1(1):75-7. PubMed ID: 10565993
    [No Abstract]   [Full Text] [Related]  

  • 13. CHH 380. Chimeric anti-CD7 antibody, SDZ CHH 380.
    Drugs R D; 1999 Jan; 1(1):73-4. PubMed ID: 10565992
    [No Abstract]   [Full Text] [Related]  

  • 14. Campath-1G. Campath IgG, Campath-1-IgG antibody.
    Drugs R D; 1999 Jan; 1(1):71-2. PubMed ID: 10565991
    [No Abstract]   [Full Text] [Related]  

  • 15. Priliximab. Anti-CD4 MAb, CEN 000029, MT 412, cMT 412, Centara.
    Drugs R D; 1999 Jan; 1(1):95-6. PubMed ID: 10565999
    [No Abstract]   [Full Text] [Related]  

  • 16. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.
    Bruley-Rosset M; Churaqui E; Annat J; Dutartre P
    Transplant Proc; 1996 Dec; 28(6):3114-6. PubMed ID: 8962208
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplant rejection. Summary and table.
    Coleman SG; Paterson R
    Drugs R D; 1999 Jan; 1(1):61-7. PubMed ID: 10565989
    [No Abstract]   [Full Text] [Related]  

  • 18. ISIS 2302. INXC ICAM1, Oligo-TCS.
    Drugs R D; 1999 Jan; 1(1):85-6. PubMed ID: 10565996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Everolimus: immunosuppression with antilymphoproliferative therapy].
    Pascual J
    Nefrologia; 2004; 24(2):112-23. PubMed ID: 15219086
    [No Abstract]   [Full Text] [Related]  

  • 20. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
    Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
    Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.